Dutton Associates Archives

WednesdayJun 27, 2007 2:43 pm

Dutton Associates Highlights: Neoprobe Corp. (NEOP.OB) with a “Strong Speculative Buy” Rating; as Company Reports Phase 2 Clinical Trial Results

Neoprobe Corporation (NEOP.OB), a diversified developer of innovative oncology and cardiovascular surgical and diagnostic products, reports positive preliminary results from a multicenter Phase 2 clinical study of its lead clinical candidate, Lymphoseek®. (Technetium Tc99m DTPA-mannosyl-dextran). Lymphoseek is a proprietary radioactive targeting agent being developed for use with handheld gamma detection devices, such as Neoprobe's neo2000® system, in a surgical procedure known as Sentinel Lymph Node Biopsy (SLNB). The primary endpoint of this multicenter, single-arm, open-label, within-patient, single-dose, multi-stage trial measured the rate at which Lymphoseek localized to lymphoid tissue with a goal of achieving 90% localization. In results reported today, localization…

WednesdayJun 27, 2007 12:38 pm

Dutton Associates Highlights: BluePoint Energy, Inc. (CPEU.OB) with Strong Speculative Buy” Rating, as Company Set to Participate in Technology Panel

Dutton Associates Highlights: BluePoint Energy, Inc. (CPEU.OB) with a "Strong Speculative Buy" Rating and a Target Price of $5.00. The Company is set to participate in a Technology Panel sponsored by FEMA taking place in New Orleans in August. Chapeau, Inc. d/b/a BluePoint Energy, Inc. (CPEU.OB) reports that it has accepted an invitation to participate in a panel discussion on the technology of Combined Heat and Power (CHP) generation as part of a one-day workshop covering 406 Hazardous Mitigation funding. The workshop is organized by the Gulf Coast CHP Application Center and sponsored by Federal Emergency Management Agency (FEMA). The workshop…

TuesdayJun 26, 2007 6:38 pm

Sunwin International Neutraceuticals (SUWN.OB) Rated “Speculative Buy” by Dutton Associates; as Company Makes Breakthrough in Foot-and-Mouth Disease

Sunwin International Neutraceuticals, Inc. (SUWN.OB), a leader in the production and distribution of Chinese herbs, veterinary medicines and one of the largest producers of low-calorie sweetener (Stevia) in China has seen a breakthrough. The Company reports that its Chinese herbal-based veterinary disinfectant named Xuyikang, has been proven to be 100% effective in preventing the spread of the Foot-and-Mouth Disease virus in an in vitro research study in baby mice infected with the virus. The research study was independently conducted by the National Food and Mouth Disease Research Laboratory of China. The test results demonstrate that Sunwin's Xuyikang Disinfectant was successful…

TuesdayJun 26, 2007 6:25 pm

Dutton Associates Maintains Lime Energy (LMEC.OB) with “Strong Speculative Buy” Rating

Dutton Associates recently updated its coverage of Lime Energy (LMEC.OB), resulting in the maintaining its rating of "Strong Speculative Buy" and increasing its target price to $2.50. The 10-page report by Dutton senior analyst Richard West, CFA is available at http://www.jmdutton.com/. Lime Energy is now one of the nation's leading energy efficiency technology and engineering companies. Through its recent acquisitions, Lime Energy brings together more than 75 years of experience in design, engineering, and installation of energy efficient solutions, providing customers with guaranteed savings and high returns on invested capital. It is a changed company, not only in name…

ThursdayJun 21, 2007 5:31 pm

Amarillo Biosciences, Inc. (AMAR.OB) Shares up 5.00% Today, as Company to be Featured Live Tomorrow on MN1

Amarillo Biosciences, Inc. (AMAR.OB) reports that Dr. Joseph Cummins, President & CEO, will be featured on Market News First (www.mn1.com). The exclusive interview with the MN1 news team is scheduled for 12:15 PM EDT on June 22. Dr. Cummins will be reviewing information about the Company's last two news releases on June 15 and June 21. These news releases reported on an upcoming clinical trial on chronic cough and additional new clinical sites for the on-going Phase 2 study in HIV+ patients Amarillo Biosciences, Inc. is a Company Covered by Dutton Associates. Amarillo Biosciences, Inc. is a U.S. biotechnology firm operating in global…

ThursdayJun 21, 2007 5:21 pm

SES Solar Inc. (SESI.OB) Maintains “Speculative Buy” Rating in Update from Dutton Associates

Dutton Associates recently updated its coverage of SES Solar (SESI.OB) and maintained its rating of "Speculative Buy" with a $2.10 price target. SES Solar was formed as a result of a September 27, 2006, reverse acquisition between SES and Societe d'Energie Solaire, a Swiss-based company that researches, develops, produces, and installs solar energy (photovoltaic or PV) products, including PV modules and roof tiles, with a special emphasis on high-quality products that can be architecturally integrated into new or existing structures. Dutton believes that SES is well positioned to benefit from soaring demand for solar energy in Europe and worldwide once it…

ThursdayJun 14, 2007 4:02 am

Dutton Associates Rated Index Oil and Gas Inc. (IXOG.OB) with a “Speculative Buy”

Index Oil and Gas is a company based out of Houston, Texas. The recently established oil and gas exploration and production company has several producing properties in Texas, Louisiana, and Kansas. Their successful drilling track record and carefully crafted operational strategy creates a sophisticated risk-management system. The independent research company is expecting sales to grow rapidly because of Oil Company’s experienced management team, growing prospective inventory in key basins, and favorable market sector outlook. They believe Index Oil and Gas should turn cash-flow positive and experience rapid growth in the longer term. They concluded the research report stating a $1.80…

TuesdayJun 12, 2007 5:09 am

Dutton Associates Rated Revett Minerals Inc. (RVM:TSK) with a $2.75 Target Price

The initial research report written on Revett Minerals commented on the company as providing “both value and upside in the Troy copper-silver mine and significant upside in a nearby world-class Rock Creek copper-silver deposit.” The Troy Mine has already been proven to be profitable and is currently increasing production. These profit are in-turn being invested directly back into the company as it develops the Rock Creek Project. The identified deposits at the two locations could support a mine life of six years for the Troy mine, and 20-plus years for the Rock Creek Project. There is great potential for the…

MondayJun 11, 2007 7:09 pm

Dutton Associates Highlights – Joystar, Inc. (JYSR.OB), as Company Adds Over 300 Travel Agents to its Network in April

Joystar, Inc. (JYSR.OB), one of the nation's fastest-growing travel agency networks and leading seller of cruises and vacations, recently reported that it added 307 travel agents to its network in the month of April. William M. Alverson, Joystar CEO, commented on the record-breaking growth, "April was our biggest month in the history of the Company in terms of new membership. With 307 agents joining our network in April and 1,145 travel agents year-to-date, we're running at nearly double last year's growth rate." A key driver to the growth of Joystar's host agency is the phenomenal success of the Company's…

MondayJun 11, 2007 6:42 pm

AZCO Mining (AZMN.OB) Rated “Strong Speculative Buy” with Target Price of $3.00 by Dutton Associates

Dutton Associates today updated its coverage of AZCO Mining (AZMN.OB) maintaining a rating of "Strong Speculative Buy" and a target price at $3.00. Dutton reiterated its investment thesis and rating for Azco Mining Inc. AZMN continues to execute on a number of its near-term objectives and has good potential to accomplish a number of milestones through the end of the year. As of February of this year, the Company caught up on its financial reporting, filing a 10KSB and two 10QSBs. In March of 2007 the Company resumed trading on the OTCBB. While Dutton looked on the filing statements and trading on…

Site Search

Company Search

Tag: Dutton Associates